Skip to content

Prospective Controlled Study of Posttransplant Diabetes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00006331
Enrollment
Unknown
Registered
2000-10-05
Start date
Unknown
Completion date
Unknown
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Kidney Failure

Keywords

Kidney transplantation, Immunology

Brief summary

Research participants will be asked to undergo complete medical history, physical examination and blood tests. The purpose of these tests is to determine whether persons are predisposed to develop diabetes mellitus after kidney transplantation and also to make an early diagnosis if a patient develops diabetes mellitus. Medical information collected as part of the standard transplant evaluation and posttransplant medical care may be incorporated into this study. It is important to realize that research subjects will not be given an experimental drug as part of this study. After kidney transplantation, research subjects will be followed in the posttransplant clinic visits. The study will last up to 6 months. During this time the subjects may be asked to participate in clinical assessment visits (medical history and physical examination), and also during the third or fourth month after transplant will be asked to do a repeat glucose tolerance test.

Interventions

PROCEDURErenal transplant

Sponsors

National Center for Research Resources (NCRR)
Lead SponsorNIH

Study design

Observational model
DEFINED_POPULATION
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Fasting Plasma Glucose (FPG) \<126mg/dl. * No history of diabetes mellitus or treatment with oral antidiabetic agent or insulin. * ESRD or chronic renal failure with CrCl \<= 20cc/min per 1.73m2. * Waiting list registration for cadaveric or set date for living donor renal transplantation. * Willingness and ability to understand and give informed consent.

Countries

United States

Contacts

Primary ContactAkinlolu O. Ojo, M.D., Ph.D.
aojo@umich.edu1-734-763-9041

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026